greeksoup/ stock research

Universal Health Services (UHS) Q3 FY2025 earnings: revenue $4.5 billion, up 13.4% on the year

Universal Health Services Inc. (UHS) reported revenue of $4.5 billion for Q3 FY2025, the quarter ended 30 September 2025, up 13.4% on the same quarter a year earlier. Net income was $373 million, up 44.2% on the year, and diluted earnings per share $5.86. The figures are the company's own, from the 10-Q it filed with the SEC on 7 November 2025.

Revenue
$4.5 billion
+13.4% on the year · +4.9% on the quarter
Q4 FY2023Q3 FY2025
Operating margin
11.6%
9.7% a year earlier
Q4 FY2023Q3 FY2025
Net income
$373 million
+44.2% on the year · +5.6% on the quarter
Q4 FY2023Q3 FY2025
Diluted EPS
$5.86
+54.2% on the year · +7.9% on the quarter
Q4 FY2023Q3 FY2025

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ3 FY2025Q2 FY2025Q3 FY2024On the quarterOn the yearLast 8 quarters
Revenue4,4954,2843,963+4.9%+13.4%
Operating income522500384+4.3%+35.8%
Operating margin11.6%11.7%9.7%
Interest expense38.435.444.7+8.7%-13.9%
Pre-tax income497473342+5.0%+45.5%
Income tax11811175.6+6.3%+55.7%
Effective tax rate23.7%23.4%22.1%
Net income373353259+5.6%+44.2%
Net margin8.3%8.2%6.5%
Diluted EPS$5.86$5.43$3.80+7.9%+54.2%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ3 FY2025Q2 FY2025Q3 FY2024On the quarterOn the yearLast 8 quarters
Operating cash flow381549333-30.7%+14.3%
Capital expenditure229266248-14.0%-7.7%
Free cash flow15228385.0-46.4%+78.5%
Free cash flow margin3.4%6.6%2.1%
Cash from investing-269-306-266
Cash from financing-135-228-89.7
Depreciation and amortisation155152150+2.0%+3.7%
Share-based compensation24.924.126.6+3.2%-6.3%
Buybacks237155183+53.0%+30.0%
Dividends paid12.512.913.3-3.3%-6.2%
Dividend per share$0.20$0.20$0.200.0%0.0%
Diluted shares, weighted64m65m68m-2.0%-6.5%
Shares outstanding at period end62m64mn/a-1.8%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ3 FY2025Q2 FY2025Q3 FY2024On the quarterOn the yearLast 8 quarters
Shareholders' equity7,1707,0306,606+2.0%+8.5%
Non-controlling interest60.855.575.4+9.6%-19.3%
Redeemable equity67.059.65.6+12.4%+1,091.2%
Debt4,7004,6004,700+2.2%0.0%
Operating lease liabilities346352378-1.6%-8.3%
Other liabilities3,0002,8892,589+3.9%+15.9%
Total liabilities and equity15,34414,98614,354+2.4%+6.9%
Fixed assets6,9736,8836,443+1.3%+8.2%
Goodwill3,9893,9783,965+0.3%+0.6%
Cash and equivalents113138106-18.0%+6.4%
Receivables2,5852,3022,214+12.3%+16.8%
Other assets1,6831,6851,625-0.1%+3.6%
Total assets15,34414,98614,354+2.4%+6.9%

Questions

What was Universal Health Services' revenue in Q3 FY2025?

Universal Health Services (UHS) reported revenue of $4.5 billion for Q3 FY2025, the quarter ended 30 September 2025, up 13.4% on the same quarter a year earlier.

How much did Universal Health Services earn in Q3 FY2025?

Net income for Q3 FY2025 was $373 million, up 44.2% on the year, and diluted earnings per share $5.86.

When did Universal Health Services report Q3 FY2025 results?

Universal Health Services filed its 10-Q for the quarter ended 30 September 2025 with the SEC on 7 November 2025.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue3,2753,2933,3233,3363,4473,4683,5483,5633,7043,8443,9083,9634,1144,1004,2844,4954,4864,4954,6384,733
Operating income314233233276261279280285331389436384472455500522517503517454
Operating margin10%7%7%8%8%8%8%8%9%10%11%10%11%11%12%12%12%11%11%10%
Interest expense19.221.725.735.743.950.948.853.453.652.848.944.739.740.135.438.442.237.139.956.3
Pre-tax income307200210234222214225221281336382342438420473497581469479414
Tax rate24%24%24%25%23%24%25%24%22%21%23%22%23%23%23%24%23%24%24%24%
Net income239154164183175163171167216262289259332317353373446349358309
Net margin7%5%5%5%5%5%5%5%6%7%7%7%8%8%8%8%10%8%8%7%
Diluted EPS$3.00$2.02$2.20$2.50$2.43$2.28$2.42$2.40$3.16$3.82$4.26$3.80$4.96$4.80$5.43$5.86$7.06$5.65$5.98$5.22
Operating cash flow32244532.6221297291363162452396679333658360549381575402443637
Capital expenditure190200208162164169168200206209241248246239266229281217228215
Free cash flow132245-17559.1133122195-38.324618843885.0412121283152293184216422
Buybacks45036620015811085.012517616214295.9183250223155237352164321245
Dividends paid15.614.914.814.614.314.214.013.713.513.613.413.313.013.512.912.512.413.011.811.8
Shares outstandingn/an/an/an/an/an/an/an/an/an/an/an/a65m64m64m62m61m61m59m58m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-Q for the period ended 30 September 2025, filed 7 November 2025: the filing.